Apixaban for treatment of venous thromboembolism (VTEtx): Use of MBMA to support Phase 3 dose selection and beyond
Apixaban is an orally available, direct, selective inhibitor of the coagulation factor Xa that reversibly…
Certara2018年6月2日
The Model-informed Precision Dosing Revolution Is Coming
Modeling and simulation (M&S) has been widely accepted and adopted by biopharmaceutical companies and global…
Certara2017年3月7日
The Pharmacokinetics of Transdermal Flunixin Meglumine in Holstein Calves
This study describes the pharmacokinetics of topical and intravenous (IV) flunixin meglumine in Holstein calves.…
Certara2016年12月1日
Pharmacokinetics of Oral Terbinafine in Adult Horses
The primary study objective was to compare the pharmacokinetics of p.o. terbinafine alone to p.o.…
Certara2016年11月24日
